A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease L Pihlstrøm, C Blauwendraat, C Cappelletti, V Berge‐Seidl, M Langmyhr, ... Annals of neurology 84 (1), 117-129, 2018 | 57 | 2018 |
A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers … D Tosun, Z Hausle, H Iwaki, P Thropp, J Lamoureux, EB Lee, K MacLeod, ... Alzheimer's & Dementia, 2024 | 1 | 2024 |
A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk A Moore, PW Crea, M Makarious, S Bandres-Ciga, C Blauwendraat, ... Neurobiology of Aging 134, 66-73, 2024 | | 2024 |
A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson's disease AAK Sreelatha, A Shadrin, C Blauwendraat, O Frei, T Gasser, G Wenning, ... MOVEMENT DISORDERS 34, S312-S314, 2019 | | 2019 |
A genome-wide genetic pleiotropy approach identified shared loci between multiple system atrophy and inflammatory bowel disease AA Shadrin, S Mucha, D Ellinghaus, MB Makarious, C Blauwendraat, ... bioRxiv, 751354, 2019 | | 2019 |
A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes K Menden, M Francescatto, T Nyima, C Blauwendraat, A Dhingra, ... Scientific data 10 (1), 849, 2023 | 3 | 2023 |
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 113 | 2019 |
A population scale analysis of rare SNCA variation in the UK Biobank C Blauwendraat, MB Makarious, HL Leonard, S Bandres-Ciga, H Iwaki, ... Neurobiology of disease 148, 105182, 2021 | 11 | 2021 |
A reference human induced pluripotent stem cell line for large-scale collaborative studies CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendraat, L Peng, ... Cell stem cell 29 (12), 1685-1702. e22, 2022 | 93 | 2022 |
A reference human induced pluripotent stem cell line for large-scale collaborative studies Authors and affiliations CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendraat, L Peng, ... | | |
Accelerating medicines partnership: Parkinson's disease. Genetic resource H Iwaki, HL Leonard, MB Makarious, M Bookman, B Landin, D Vismer, ... Movement Disorders 36 (8), 1795-1804, 2021 | 74 | 2021 |
Adaptive Long‐Read Sequencing Reveals GGC Repeat Expansion in ZFHX3 Associated with Spinocerebellar Ataxia Type 4 Z Chen, EK Gustavsson, H Macpherson, C Anderson, C Clarkson, ... Movement Disorders 39 (3), 486-497, 2024 | 13 | 2024 |
ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies C Blauwendraat, MA Nalls, M Federoff, O Pletnikova, J Ding, C Letson, ... Movement disorders: official journal of the Movement Disorder Society 32 (2 …, 2017 | 11 | 2017 |
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1 P Alvarez Jerez, PA Wild Crea, D Ramos, EK Gustavsson, M Radefeldt, ... medRxiv, 2024.02. 20.24302827, 2024 | | 2024 |
alpha-Synuclein in sympathetic nerve fibers distinguishes PRKN from LRRK2 and other genetic forms of Parkinson's Disease R Isonaka, D Goldstein, W Zhu, E Yoon, D Ehrlich, A Schindler, A Kokkinis, ... MOVEMENT DISORDERS 36, S311-S313, 2021 | | 2021 |
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of a-synuclein E Kara, A Crimi, A Wiedmer, M Emmenegger, C Manzoni, S Bandres-Ciga, ... bioRxiv, 2019.12. 23.886838, 2019 | | 2019 |
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein E Kara, A Crimi, A Wiedmer, M Emmenegger, C Manzoni, S Bandres-Ciga, ... Cell reports 35 (10), 2021 | 9 | 2021 |
An introduction to the Global Parkinson's Genetics Program (GP2) C Blauwendraat, E Riley, A Singleton MOVEMENT DISORDERS 35, S195-S195, 2020 | | 2020 |
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease EE Brown, C Blauwendraat, J Trinh, M Rizig, MA Nalls, E Leveille, ... Neurobiology of Aging 97, 148. e17-148. e24, 2021 | 23 | 2021 |
Analysis of rare Parkinson’s disease variants in millions of people M Nalls, K Heilbron, C Blauwendraat | | |